Cowealth Medical China Co.Ltd. (603122.SS) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE100005R39
Cowealth Medical China Co.Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 939.14 m CNY | 677.79 m CNY |
| Gross profit | 184.09 m CNY | 100.01 m CNY |
| Operating income | 36.08 m CNY | -23.53 m CNY |
| EBIT | 42.79 m CNY | -37.80 m CNY |
| Net income | 27.57 m CNY | -33.64 m CNY |
| Diluted EPS – continuing operations | 0.07 CNY | -0.08 CNY |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cowealth Medical China Co.Ltd.
Cowealth Medical China Co.,Ltd. operates as a medical company in China. It offers centralized procurement services for in-vitro diagnostic reagents and consumables; platform for decision-making and analysis, commercialization of achievements in medical science and technology; a multi-channel coaxial time audio video imaging platform; and an AI-assisted system for clinical diagnosis. The company was founded in 1997 and is based in Shanghai, China.
More stocks
- Holding Bursátil Regional S.A. (NUAM.SN)
- Capital Bancorp Inc (CBNK)
- BAR HARBOR BANKSHARES (BHB)
- ArriVent BioPharma, Inc. (AVBP)
- ACHIEVE LIFE SCIENCES, INC. (ACHV)
- Jumia Technologies AG (JMIA)
- Cyber_Folks SA (CBF.WA)
- Henan Lantian Gas Co Ltd (605368.SS)
- Jiangyin Haida Rubber and Plastic Co Ltd Class A (300320.SZ)
- Lingda Group Co Ltd (300125.SZ)
- PennyMac Mortgage Investment Trust (PMT)
- New Found Gold Corp (NFGC)
Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.